Primary analysis of the prospective, randomized, single-blinded phase II trial of AE37 vaccine versus GM-CSF alone administered in the adjuvant setting to high-risk breast cancer patients.
Elizabeth Ann Mittendorf
No relevant relationships to disclose
Erika J Schneble
No relevant relationships to disclose
Sonia A. Perez
No relevant relationships to disclose
James T Symanowski
Consultant or Advisory Role - Antigen Express
Ritesh Patil
No relevant relationships to disclose
Timothy J. Vreeland
No relevant relationships to disclose
John S. Berry
No relevant relationships to disclose
Alfred F Trappey
No relevant relationships to disclose
Guy T. Clifton
No relevant relationships to disclose
Eric von Hofe
Employment or Leadership Position - AntiCen Express
Alexandros Ardavanis
No relevant relationships to disclose
Sathibalan Ponniah
No relevant relationships to disclose
Nathan M. Shumway
No relevant relationships to disclose
Michael Papamichail
No relevant relationships to disclose
George Earl Peoples
Consultant or Advisory Role - Antigen Express